Nextgen Biomed Ltd

Tel Aviv Stock Exchange NXGN.TA

Nextgen Biomed Ltd Gross Profit Margin for the year ending December 31, 2023

Nextgen Biomed Ltd Gross Profit Margin is NA for the year ending December 31, 2023. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA

Nextgen Biomed Ltd

CEO Mr. Harel Hershtik
IPO Date Aug. 12, 2002
Location Israel
Headquarters 132 Azrieli Towers Round Building
Employees 5
Sector Health Care
Industries
Description

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email